Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Phase 2 study of pembrolizumab and chemotherapy in patients with newly diagnosed classical Hodgkin Lymphoma
Phase: 2Phase II in Spain, 1Phase I